Department of Pharmaceutics, Dubai Pharmacy College for Girls, Dubai, United Arab Emirates.
Curr Pharm Des. 2024;30(15):1200-1208. doi: 10.2174/0113816128297499240321034304.
This invention reports the solubilization of Acetaminophen (ACM) within the Povidone (PVP K30) in the solid state for the first time.
First-generation solid dispersions (SDs) were attempted with a different ratio of PVP K:30:ACM. SDs prepared were transparent, suggesting a solid solution (SS) formation, which was a serendipitous discovery. A minimum ratio of 1.25:1 PVP K30: ACM was required to form stable SS, suggesting discontinuous SS. A computational complex prediction tool, fourier transform infrared spectroscopy (FTIR), and differential scanning calorimetry (DSC) confirmed the SS formation.
The oral strip formulation was developed from the PVP K30: ACM SS using Polyvinyl alcohol as a film-former found to be optimum concerning physicochemical properties, offering rapid drug dissolution and taste masking.
The designed strip is suitable for delivering a child's dose (100-150 mg). However, the developed SS can be formulated as tablets, capsules, or oral dissolving tablets to deliver adult doses with improved therapeutic benefits and patient compliance.
本发明首次报道了将对乙酰氨基酚(ACM)在固态下溶解于聚乙烯吡咯烷酮(PVP K30)中。
尝试了第一代具有不同 PVP K:30:ACM 比例的固体分散体(SD)。制备的 SD 是透明的,表明形成了固溶体(SS),这是一个偶然的发现。形成稳定 SS 所需的 PVP K30:ACM 的最小比例为 1.25:1,表明 SS 是不连续的。计算复杂预测工具傅里叶变换红外光谱(FTIR)和差示扫描量热法(DSC)证实了 SS 的形成。
使用聚乙烯醇作为成膜剂,从 PVP K30:ACM SS 开发了口服条带制剂,该制剂在物理化学性质方面表现出最佳性能,提供了快速的药物溶解和掩盖味道。
设计的条带适合儿童剂量(100-150mg)的给药。然而,开发的 SS 可以制成片剂、胶囊或口腔溶解片剂,以提供改善的治疗效果和提高患者顺应性的成人剂量。